Business Context and Reporting Period
This Form 8-K is filed by Marathon Patent Group, Inc. (not MARA Holdings, Inc.) for the reporting period of March 16, 2015. The filing addresses corporate governance changes, specifically a director resignation and subsequent appointment, and a resulting notice from Nasdaq regarding listing compliance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on governance and equity compensation events.
Material Changes
- Director Resignation: Stuart Smith resigned from the Board of Directors effective March 3, 2015, for personal reasons.
- Nasdaq Compliance Notice: On March 16, 2015, the Company received notice from Nasdaq that it no longer complies with Listing Rule 5605 (audit committee requirements) due to the resignation.
- Cure Period: Nasdaq granted a cure period until the earlier of the next annual shareholders' meeting or March 3, 2016 (or August 31, 2015, if the meeting occurs before that date).
- New Director Appointment: On March 18, 2015, the Board appointed Dirk Tyler to fill the vacancy. Mr. Tyler is deemed independent and will serve on the Compensation, Audit, and Nominating and Corporate Governance Committees.
Guidance, Outlook, and Unusual Items
The filing contains no financial guidance, outlook, or management commentary regarding future performance. The primary unusual item is the temporary non-compliance with Nasdaq listing standards, which the Company states has been remedied by the appointment of Mr. Tyler.
Equity Compensation: The Board approved the issuance of options to purchase 20,000 shares of common stock to Mr. Tyler under the 2014 Equity Incentive Plan, subject to shareholder approval. Details include:
- Exercise Price: $6.61 per share (closing price on March 18, 2015).
- Expiration Date: March 18, 2020.
- Vesting Schedule: Pro rata monthly over twelve months, contingent on continuous Board membership.
Investor Verification Checklist
- Verify the status of shareholder approval for the 20,000 stock options granted to Dirk Tyler.
- Confirm the date of the next annual shareholders' meeting to determine the exact deadline for Nasdaq compliance.
- Review the Company's most recent 10-K or 10-Q for financial metrics, as this 8-K contains no financial data.
- Monitor future filings to ensure the Company formally notifies Nasdaq of regained compliance.